Nov 21, 2022 by James HalleyWarren Buffett Likes This Passive Income StockMcKesson has many of the hallmarks of the type of stable company Berkshire Hathaway likes to own.
Nov 20, 2022 by James Halley2 Reasons to Buy Pfizer and 1 Reason to SellThe pharmaceutical company is looking for a future beyond COVID-19 therapies.
Nov 20, 2022 by James Halley3 Top Cannabis Stocks to Buy in NovemberThese solid performers are managing to grow revenue in a difficult environment.
Nov 19, 2022 by James Halley2 Breakout Growth Stocks to Buy for the Long HaulThese two Russell 1000 members know how to grow revenue.
Nov 18, 2022 by James HalleyWhy Shares of Cano Health Plummeted 29.5% This WeekThe value-based healthcare insurer is seen as a potential buyout candidate.
Nov 18, 2022 by James HalleyWhy Shares of GoodRx Holdings Fell 18.7% Lower This WeekThe company, which focuses on delivering prescription drug discounts, has struggled this year.
Nov 17, 2022 by James HalleyWhy Shares of Compugen Jumped 17.86% on ThursdayThe company is receiving a $7.5 milestone payment from AstraZeneca for the use of one of its therapies.
Nov 17, 2022 by James HalleyWhy Editas Medicine's Shares Are Falling ThursdayThe company shelved a clinical trial for one of its lead therapies.
Nov 17, 2022 by James HalleyWhy Shares of Affimed Fell ThursdayThe clinical-stage biotech focuses on immuno-oncology therapies.
Nov 17, 2022 by James Halley2 Reasons to Buy Abbott Labs and 1 Reason to SellThe healthcare company offers growth and value.
Nov 16, 2022 by James HalleyWhy Shares of Brookdale Senior Living Tumbled 33.23% on WednesdayInvestors weren't happy when the company began a public offering of 2.5 million tangible equity units.
Nov 15, 2022 by James HalleyWhy Shares of Twist Bioscience Fell 19.92% on TuesdayA negative report by a short-seller drove the biotech's shares downward.
Nov 15, 2022 by James HalleyWhy Shares of Invitae Rose 11% on TuesdayInvestors continue to be encouraged by the company's cost-cutting attempts.
Nov 15, 2022 by James HalleyWhy Rite Aid Stock Jumped by 15.6% TuesdayThe pharmacy chain operator's shares hit their highest level in more than a month.
Nov 15, 2022 by James HalleyWhat the Election Results Mean for Cannabis REITsThese two REITs have plenty of tailwinds.
Nov 14, 2022 by James Halley3 Stocks With Dividends of 3% or More to Buy on the DipThree underpriced healthcare stocks provide an opportunity.
Nov 12, 2022 by James Halley2 No-Brainer Stocks to Buy Right Now for Less than $20These stocks are still bargain-priced but benefit from long-term trends.
Nov 11, 2022 by James HalleyWhy Shares of TG Therapeutics Climbed 59.9% This WeekThe company got a big bump from the FDA.
Nov 11, 2022 by James HalleyWhy Shares of NeoGenomics Jumped 53.9% This WeekThe cancer screening company showed its turnaround may be working.
Nov 11, 2022 by James HalleyWhy Certara's Shares Rose 37.7% This WeekThe company, which helps other companies in their drug development, reported strong third-quarter numbers.
